The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 31 October 2006, www.theannals.com, DOI 10.1345/aph.1H379.
 The Annals of Pharmacotherapy: Vol. 40, No. 12, pp. 2248-2250. DOI 10.1345/aph.1H379
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, C M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, C M.

Ensuring that Patients Receive Full Cardiac Pharmacotherapy Services: A Pharmacist's Call to Arms

C Michael White, PharmD FCCP FCP

Associate Professor, School of Pharmacy, University of Connecticut, Storrs, CT; Director, Cardiac Pharmacology Service, Hartford Hospital, Hartford, CT

Reprints: Dr. White, Drug Information Center, Hartford Hospital, Hartford, CT 06102-5037, fax 860/545-2277, cmwhite{at}harthosp.org

While clinical trials have proven that use of certain cardiovascular drugs improves morbidity and mortality, these drugs are not widely used, they are by and large prescribed in suboptimal doses, and their benefit is further diminished by nonadherence. Pharmacists have the ability to improve the survival of patients with cardiovascular risks. This can only be accomplished through the efforts of the individual pharmacist and the further development of health-system management services. Pharmacists need to leverage their access to patients, their large patient base, and their knowledge of refill dates to improve patient care. Support and development of more pharmacist-directed anticoagulation, hyperlipidemia, and hypertension clinics are also needed.

Key Words: cardiovascular drugs, pharmacotherapy services

Published Online, October 31, 2006. www.theannals.com, DOI 10.1345/aph.1H379


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Lertsburapa, C. M. White, J. Kluger, O. Faheem, J. Hammond, and C. I. Coleman
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 405 - 411.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.